SkinLesNet: Classification of Skin Lesions and Detection of Melanoma Cancer Using a Novel Multi-Layer Deep Convolutional Neural Network.

Simple Summary: While melanoma accounts for 4% of skin cancer cases, it causes 75% of skin-cancer-related deaths. The survival rate for melanoma is higher for early-identified cases, so improved access to diagnosis and screening programs is essential for addressing skin cancer deaths. Computer-aided diagnosis utilizing machine learning can be used to differentiate malignant and benign skin lesions. There is significant research into the use of convolutional neural networks to classify skin lesions from dermoscopic images. However, to provide cost-effective and accessible options for early detection of malignant melanoma, smartphone applications capable of accurately classifying skin lesions from images taken on a smartphone would be beneficial. This research investigates a previously underexplored dataset of smartphone images and develops a novel multi-layer deep convolutional neural network model, named SkinLesNet, to classify three types of skin lesions, including melanoma. Further studies to validate the model should be conducted as other image datasets become available. Skin cancer is a widespread disease that typically develops on the skin due to frequent exposure to sunlight. Although cancer can appear on any part of the human body, skin cancer accounts for a significant proportion of all new cancer diagnoses worldwide. There are substantial obstacles to the precise diagnosis and classification of skin lesions because of morphological variety and indistinguishable characteristics across skin malignancies. Recently, deep learning models have been used in the field of image-based skin-lesion diagnosis and have demonstrated diagnostic efficiency on par with that of dermatologists. To increase classification efficiency and accuracy for skin lesions, a cutting-edge multi-layer deep convolutional neural network termed SkinLesNet was built in this study. The dataset used in this study was extracted from the PAD-UFES-20 dataset and was augmented. The PAD-UFES-20-Modified dataset includes three common forms of skin lesions: seborrheic keratosis, nevus, and melanoma. To comprehensively assess SkinLesNet's performance, its evaluation was expanded beyond the PAD-UFES-20-Modified dataset. Two additional datasets, HAM10000 and ISIC2017, were included, and SkinLesNet was compared to the widely used ResNet50 and VGG16 models. This broader evaluation confirmed SkinLesNet's effectiveness, as it consistently outperformed both benchmarks across all datasets. [ABSTRACT FROM AUTHOR]